Cystic Fibrosis - Insulin Deficiency, Early Action
Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
Cystic Fibrosis (CF) is the most common life-threatening genetic condition affecting
Australian children. As well as repeated lung infections, children with CF develop insulin
deficiency and eventually diabetes. The CF-IDEA trial (Cystic Fibrosis - Insulin Deficiency,
Early Action) will determine whether starting insulin treatment before the onset of diabetes
(earlier than current practice) will improve the health of children with CF by improving body
weight and lung function.
Phase:
Phase 3
Details
Lead Sponsor:
Sydney Children's Hospitals Network Sydney Children's Network
Collaborators:
Children's Hospital Colorado John Hunter Children's Hospital Lady Cilento Children's Hospital, Brisbane Women's and Children's Hospital, Adelaide